Michael Torres

Title: Michael Torres: Innovator in Polynucleotide Compositions

Introduction

Michael Torres is a notable inventor based in Menlo Park, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of polynucleotide compositions. His work focuses on innovative methods for treating conditions associated with cystic fibrosis.

Latest Patents

Michael Torres holds a patent for "Polynucleotide compositions, related formulations, and methods of use thereof." This patent discloses compositions of polynucleotide(s), pharmaceutical compositions thereof, and methods of use. The polynucleotide may encode for a cystic fibrosis transmembrane conductance regulator (CFTR) protein or a functional fragment thereof. Additionally, the polynucleotide can be assembled with a lipid composition for targeted delivery to a cell or an organ, such as a lung cell or a lung of a subject. The patent also provides methods for enhancing the expression or activity of CFTR protein in a cell, as well as methods for treating subjects with CFTR-associated conditions. Michael Torres has 1 patent to his name.

Career Highlights

Michael Torres is currently employed at Recode Therapeutics, Inc., where he continues to advance his research in the field of gene therapy and biotechnology. His innovative work has the potential to significantly impact the treatment of genetic disorders.

Collaborations

Michael collaborates with talented individuals such as Mirko Hennig and Daniella Ishimaru, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Michael Torres is a pioneering inventor whose work in polynucleotide compositions is paving the way for new treatments for cystic fibrosis and related conditions. His contributions to biotechnology are noteworthy and hold promise for future advancements in the field.